INVOLVEMENT OF PROTEIN-KINASE-C IN THE INTERLEUKIN-1 ALPHA-INDUCED GENE-EXPRESSION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR-1 OF METALLOPROTEINASES (TIMP-1) IN HUMAN UTERINE CERVICAL FIBROBLASTS
S. Takahashi et al., INVOLVEMENT OF PROTEIN-KINASE-C IN THE INTERLEUKIN-1 ALPHA-INDUCED GENE-EXPRESSION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR-1 OF METALLOPROTEINASES (TIMP-1) IN HUMAN UTERINE CERVICAL FIBROBLASTS, Biochimica et biophysica acta, 1220(1), 1993, pp. 57-65
The role of protein kinase C in the interleukin 1 (IL-1)-mediated prod
uction of pro-matrix metalloproteinases (proMMPs) and tissue inhibitor
-1 of metalloproteinases (TIMP-1) in human uterine cervical fibro-blas
ts has been investigated. IL-1 and a protein kinase C activator, 12-O-
tetradecanoylphorbol 13-acetate (TPA) augmented the production of proM
MP-1 (interstitial procollagenase), proMMP-3 (prostromelysin-1) and TI
MP-1, but their effects were inhibited by the protein kinase C inhibit
ors 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7
) and staurosporine in a dose-dependent manner. The suppressive effect
of H-7 and staurosporine on the IL-1-induced production of proMMPs-1
and -3 and TIMP-1 resulted from the decrease in the steady-state level
s of their mRNAs. When protein kinase C was down-regulated by treating
the cells with a high level of TPA, the inductive effect of IL-1 upon
proMMP-3 production was reduced considerably. These results indicate
that protein kinase C mediates the IL-1-induced production of proMMPs-
1 and -3 and TIMP-1 at the pretranslational level in human uterine cer
vical fibroblasts. On the other hand, neither IL-1 nor TPA modulated t
he production of proMMP-2 (progelatinase A). Both IL-1 and TPA also ac
celerated the production of prostaglandin E2 (PGE2) by cervical fibrob
lasts. However, the treatment of the cells with staurosporine in the p
resence of IL-1 or TPA further augmented PGE2 synthesis, suggesting th
at the increased synthesis of PGE2 by IL-1 treatment is mediated via s
ignalling pathways distinct from those of proMMPs-1 and -3 and TIMP-1.